# Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

> **NCT03559582** · — · COMPLETED · sponsor: **University of Virginia** · enrollment: 478 (actual)

## Conditions studied

- Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03559582
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-28
- **Primary completion:** 2020-07-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 478 (ACTUAL)
- **Last updated:** 2022-03-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03559582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03559582, "Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03559582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*